Macitentan 10 mg

What is Macitentan 10 mg?

Macitentan 10 mg is a prescription medication specifically formulated to manage pulmonary arterial hypertension (PAH). It contains the active ingredient Macitentan, which belongs to a class of drugs known as endothelin receptor antagonists. This medication is designed to help improve blood flow and reduce the strain on the heart caused by elevated blood pressure in the arteries of the lungs.

Manufactured by Cipla Limited, a reputable pharmaceutical company, Macitentan 10 mg offers an advanced treatment option for patients diagnosed with PAH. This condition, if left untreated, can significantly impact lung and heart function, making effective management essential for maintaining quality of life.

Uses of Macitentan 10 mg

• Management of pulmonary arterial hypertension (PAH)
• Improving exercise capacity in PAH patients
• Slowing the progression of PAH
• Reducing hospitalization rates associated with PAH complications

How Macitentan 10 mg Works

Macitentan works by blocking endothelin receptors in the walls of blood vessels located in the lungs. Endothelin is a substance that causes blood vessels to constrict and narrow, raising blood pressure within the lungs. By antagonizing endothelin receptors, Macitentan helps relax these blood vessels, promoting better blood flow and reducing pulmonary arterial pressure. This mechanism helps alleviate the workload on the heart and supports healthier lung function.

Benefits of Macitentan 10 mg

• Improves exercise tolerance and physical activity levels
• Helps decrease symptoms associated with PAH such as shortness of breath
• Potentially delays disease progression
• Supports better heart function by lowering pulmonary artery pressure
• Oral administration provides convenient dosing

Dosage and Administration

The recommended dose of Macitentan 10 mg is typically one tablet taken once daily, with or without food. It is important to follow your healthcare provider’s instructions carefully and not to alter the dosage without professional advice. Regular monitoring of liver function and blood counts is advised during treatment. Consistency in taking the medication is key to achieving optimal therapeutic effects.

Who Should Use Macitentan 10 mg?

Macitentan 10 mg is intended for adults diagnosed with pulmonary arterial hypertension. It is suitable for patients who require long-term treatment to improve symptoms and manage their condition. A healthcare provider will assess if this medication fits individual health profiles and therapeutic needs.

Who Should Avoid Macitentan 10 mg?

Patients with known hypersensitivity to Macitentan or any of its excipients should avoid this medication. It is not recommended during pregnancy due to potential risks to the fetus. People with severe liver impairment or significant hypotension should discuss alternative treatments with their physician. Always inform your healthcare provider of your full medical history before starting treatment.

Side Effects

• Headache
• Nasopharyngitis (common cold symptoms)
• Fatigue
• Anemia (low red blood cell count)
• Fluid retention or swelling
• Nausea
• Upper respiratory tract infections
• Dyspnea (shortness of breath)

Safety Advice

• Consult a healthcare professional prior to starting Macitentan
• Do not use during pregnancy; effective contraception is advised
• Attend regular blood tests to monitor liver and blood health
• Inform your doctor if you experience unusual bleeding or bruising
• Avoid combining with other endothelin receptor antagonists, such as bosentan or ambrisentan
• Report any signs of liver damage, such as jaundice or dark urine

Drug Interactions

• May interact with strong CYP3A4 inhibitors (e.g., ketoconazole)
• Potential interaction with CYP3A4 inducers (e.g., rifampicin)
• Caution when combined with other PAH therapies, such as riociguat
• Inform your doctor about all medications and supplements you are taking

Storage Instructions

Store Macitentan 10 mg tablets in a cool, dry place away from direct sunlight. Keep the medication out of reach of children. Ensure the container is tightly closed to maintain medication integrity. Do not use past the expiration date indicated on the packaging.

Where to buy Macitentan 10 mg in Canada?

In Canada, Macitentan 10 mg can be purchased at licensed pharmacies with a valid prescription from a healthcare provider. It is recommended to buy from reputable pharmacies or certified online platforms to ensure authenticity and safe handling. Always verify the credentials of the seller prior to purchase.

Frequently Asked Questions (FAQ)

Is Macitentan 10 mg available in Canada?

Yes, Macitentan 10 mg is available in Canada by prescription through licensed pharmacies.

What is the price of Macitentan 10 mg in Canada?

The price of Macitentan 10 mg varies depending on the pharmacy and insurance coverage. It is advisable to check with local pharmacies or online stores for current pricing.

What happens if I miss a dose?

If you miss a dose, take it as soon as you remember on the same day. Do not double dose the next day. Consult your healthcare provider if you are unsure about missed doses.

Where can I find Macitentan 10 mg for sale?

Macitentan 10 mg can be found at licensed pharmacies across Canada, including some verified online pharmacies requiring a prescription.

Can Macitentan 10 mg be taken with other medications?

Some medications may interact with Macitentan 10 mg. Always inform your doctor about all medicines and supplements you are currently using to avoid interactions.

Are there any dietary restrictions while taking Macitentan 10 mg?

No specific dietary restrictions are required, but maintaining a healthy diet supports overall treatment success.

How long does it take for Macitentan 10 mg to show effects?

Improvement may be noticed within weeks; however, full benefits can take several months. Regular follow-up with your doctor is important to assess treatment progress.

Conclusion

Macitentan 10 mg is a valuable pharmaceutical intervention for individuals living with pulmonary arterial hypertension. Manufactured by Cipla Limited, this medication offers a well-tolerated, effective means of managing PAH symptoms and improving quality of life. By blocking endothelin receptors, Macitentan helps reduce pulmonary blood pressure, easing the workload on the heart. When used according to medical guidance, it can be an essential part of a comprehensive treatment strategy. Patients in Canada can access this medication through licensed pharmacies with a prescription, ensuring safe and reliable care. The SERAPHIN trial of macitentan reports its effect on morbidity and mortality in pulmonary arterial hypertension. You can also browse our pulmonary arterial hypertension medicines.